Astrazeneca PLC (AZN) SEC Filings — 2026
6 SEC filings for Astrazeneca PLC (AZN) in 2026.
Filings
- AstraZeneca's Tezepelumab Shows Positive Phase III COPD Results — 6-K · Apr 20, 2026
- AstraZeneca PLC Reports AGM Results — 6-K · Apr 9, 2026
- AstraZeneca Securities Delisted by NYSE — 25-NSE · Apr 8, 2026
- AstraZeneca's Liver Cancer Drug Combo Shows Improved PFS — 6-K · Apr 2, 2026
- AstraZeneca PLC Files 6-K on Voting Rights — 6-K · Apr 1, 2026
- AstraZeneca's IMFINZI Shows Positive Phase III Lung Cancer Results — 6-K · Mar 31, 2026